Ameriprise Financial AMP

Financial Services · Asset Management · Synthos Deep Dive · 2026-07-03

$559.32

Buy — Tactical

—

The Overview

Ameriprise is the company behind a big network of financial advisors — the people who manage retirement accounts and investments for ordinary households — plus a fund business (Columbia Threadneedle) and an insurance/annuity arm (RiverSource). It makes money on fees from the $1.7 trillion of client money it oversees, and on the interest it earns holding clients' cash.

The stock is cheap relative to how much profit the company makes: you're paying about 12 years of current earnings, versus 20-plus for the average big company. Management is very shareholder-friendly — it returned 88% of its profit to owners last quarter through buybacks and a just-raised dividend. Our verdict is Buy — Tactical: a good, cheap business worth owning for a re-rating, but not a table-pounder, because no expert we track has a real view on it and its profits rise and fall with the stock market.

Here's what our three scores mean in everyday terms:

Downside Risk 4/10 (fairly low). It has more cash than debt and the stock is cheap, which cushions the downside — but the shares still swing a bit more than the market, and profits shrink in a market crash.
Growth Quality 6/10 (solid, not spectacular). Extremely profitable and steady, but the underlying business grows slowly; a lot of the per-share growth comes from buying back stock.
Exponential Potential 3/10 (low). This is a mature, steady grower — do not expect it to multiply. It compounds; it does not explode.

The one big worry: its earnings lean on two things it doesn't control — the level of the stock market (which sets its fee income) and interest rates (which set what it earns on client cash). If markets fall and rates get cut at the same time, both engines slow together.

Putting a number on it: our fair-value estimate is $600 against a current price of $559.32 — real upside if our numbers are right.

Target entry zone $526 – $559 accumulate in this band; ideal adds on a dip toward the 50-day average near $526, keeping roughly a 7% margin below our $600 base-case fair value

Our summary metrics

Downside Risk (lower = safer)4/10Moderate

Net cash, 12× trailing, elite 54% ROE — but beta 1.17, equity-market-beta earnings & a 15% drawdown.

Growth Quality6/10High

~14% forward EPS CAGR on buybacks + spread income; 54% ROE, but only ~5% revenue CAGR.

Exponential Potential3/10Low

Mature capital-return compounder — decelerating, ~$44B cap in a slow-growth category; not an exponential.

Fair value$600 $430–$780

What does “fair value” mean?

Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.

The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, plus an independent, public-math cross-check further down the page (“Check our number”) so you can judge it for yourself.

What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)

Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.

Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.

WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.

HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.

AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.

Exponential Potential

Exponential Potential3/10Low

Mature capital-return compounder — decelerating, ~$44B cap in a slow-growth category; not an exponential.

What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.

Deeper analysis

Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.

Check our number Market-implied growth ≈ 16%/yr This isn’t how we calculate fair value — it’s public math you can verify yourself. To justify today’s $559, earnings would have to compound roughly 16% a year for 10 years (9% discount rate). Analysts forecast ~15%/yr, so the market is pricing in about what the Street expects.

Reference table

Street consensus	$514 (high $582 / low $467; 1 Strong Buy · 10 Buy · 10 Hold · 1 Sell) — context, not our anchor
Valuation	12× trailing EPS · 11× FY26E · 10× FY27E · 7.5× FY29E · EV/EBITDA 7.3× · P/B 7.3×
Technicals	Mixed — $489, −10% off 52-wk high, above 50-DMA but ~flat vs 200-DMA, RSI 70 (near overbought), −9% 12-mo (SPY +21%)
Conviction	Low — 0 usable expert voices; the call rests entirely on cheap multiple + elite ROE + capital return
Position sizing	Satellite value/quality, ~2–3% — a re-rating trade, not a core conviction holding

What the experts actually said 1 traceable claims on AMP · showing the highest-conviction voices

“Infrastructure is consolidating and being hoarded like 1800s factory generators; the fix is open, shared infrastructure — an AI grid with baseload plus spikes, which AMP is building.”

Jensen Huangbullishconviction 752026-03-25jensen_huang-H26xnpL-ei0:959dc083da

Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.

Price & moving averages 12 months · 50 & 200-day averages · 52-week range

Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.

Bollinger Bands 20-day average ± 2 standard deviations

The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.

RSI (14) momentum gauge · 0–100

Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 58.

MACD 12 / 26 / 9 · trend & momentum

The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.

Relative performance vs S&P 500 & its sector (XLF (sector)), set to 100 a year ago

Solid = AMP · dashed = S&P 500 · dotted = XLF (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.

Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate

Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.

Key stats an RIA wants

Price$559.32

Market cap$50B

P/E trailing13×

P/E FY26E / FY27E12× / 11×

EV / Sales2.3×

EV / EBITDA8.5×

Gross margin50.2%

Net margin19.9%

Dividend yield1.18%

Beta1.137

52-wk range$430 – $571

RSI(14)51

50 / 200-DMA$526 / $485

12-mo return+8% (SPY +19%)

Street target$557 ($489–$645)

Analyst grades10 Buy · 10 Hold · 1 Sell

FMP ratingB+

Next earnings2026-07-23 (Q2'26 earnings; Street EPS est $10.63)

1. What it is

Ameriprise Financial (NYSE: AMP) is a ~130-year-old Minneapolis-based diversified financial-services holding company — advice, asset management, and insurance — spun out of American Express in 2005. Fiscal year ends December 31. It oversees roughly $1.7 trillion in assets under management, administration and advisement. It runs three operating segments plus Corporate & Other:

Advice & Wealth Management (AWM) — the crown jewel: financial planning and full-service brokerage through a large advisor force. Q1'26 pretax margin 30%, adjusted net revenue per advisor at a record ~$1.2M (TTM).
Asset Management — Columbia Threadneedle, institutional and retail funds. Q1'26 pretax margin ~44%; the structural pressure point is net outflows (Q1'26 total net AUM/AUA outflows of −$5.9B, though improving from −$18.3B a year ago).
Retirement & Protection Solutions (RiverSource) — annuities, life, disability income.

Segment revenue mix (FY2025, from filings):

Advice & Wealth Management $12.17B (~64%) · Retirement & Protection $3.96B (~21%) · Asset Management $3.62B (~19%) (segment sum exceeds the $18.9B consolidated total because of Corporate & intersegment items).
The business has shifted decisively toward AWM — that segment nearly doubled from $6.7B (2020) to $12.2B (2025), a genuine positive mix change toward the highest-quality, most-recurring revenue.

Geography: overwhelmingly US. FMP's geo segmentation is stale (only legacy "Non-US" lines), but the business is US-concentrated — a pricing-power strength and a US-market/policy concentration risk.

2. The expert thesis — why the panel is (not) here (honest)

There is no usable expert coverage of Ameriprise in the Synthos knowledge base. total_claims = 3, but on inspection none of the three claims are actually about Ameriprise Financial:

Two "bullish" claims (jensen_huang-H26xnpL-ei0:959dc083da, jensen_huang_ai-H26xnpL-ei0:5e33064f11) describe an AI-compute "grid" / datacenter-power company — that is not Ameriprise, a financial advisor. These are a ticker collision (the "AMP" symbol matching an unrelated AI-infrastructure reference) and carry zero weight here. I will not launder them into false conviction.
The one "bearish" claim (eurodollar_university-j-JYdbUmThU:7243602aca) references "AMP trimming 'frothy' assets" alongside HSBC and a private-credit pullback — an institutional-flows macro note whose "AMP" is ambiguous and not clearly Ameriprise; treated as non-probative.

So the honest position: breadth 0, net conviction 0. This verdict is entirely fundamentals- and quant-driven — cheap multiple, elite ROE, aggressive capital return, offset by market/rate cyclicality and slow organic growth. No expert is pounding the table for or against this name in our system, and I will not pretend otherwise. That is a reason for a smaller position and the "Tactical" (not "Core") label, not a reason to fabricate a thesis.

3. Synthos scores & the Bull / Base / Bear cases

The one-glance judgment — three scores, 0–10, each anchored to real metrics:

Score	0–10	The read
Downside Risk (lower = safer)	4 · Low-Moderate	Net cash (net-debt/EBITDA −0.95×), 12× trailing, elite 54% ROE and a modest ~25% payout cushion the downside — but beta 1.17, a −15% max drawdown, and earnings levered to equity markets + cash-sweep spread keep it from "safe."
Growth Quality	6 · Solid	~14% forward EPS CAGR and a favorable mix shift toward wealth management with a 54% ROE — but revenue CAGR is only ~5%, so much of the per-share growth is buyback-driven, not organic.
Exponential Potential	3 · Low	A mature ~$44B capital-return compounder in a slow-growth category; growth is decelerating and there is no accelerating second derivative or vast untapped TAM. Compounds, does not explode.

The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is the expected path, and the cases bound the range.

Case	Key assumptions	Fair value
Bull	Equity markets rise, cash-sweep spread holds, asset-management outflows turn to inflows; FY27E EPS beats toward ~$52 on continued buybacks; multiple re-rates to ~15× (toward peer asset managers).	~$780 (+59%)
Base (our anchor)	Estimates roughly hit — FY27E EPS ~$48; a 54%-ROE compounder with steady buybacks earns a modest re-rate to ~12.5×.	~$600 (+23%)
Bear	Market drawdown compresses fee AUM and net flows; rate cuts squeeze spread income; FY26 EPS slips toward ~$40 and the multiple stays ~10×.	~$430 (−12%)

Synthos fair value = the base case, ~$600 (+23%), with the full $430–$780 span as the honest range. This anchor sits above the Street's $514 consensus because we give credit to the buyback-driven EPS path and a partial re-rate off a depressed 12× multiple. This is a tracked call — the Forecaster Scorecard grades it once it matures. Note the multiple, not the earnings, does the heavy lifting in the bull case — a value re-rating trade.

4. Exponential Potential

Synthos separates compounders (durable high returns on capital) from exponentials (accelerating multi-baggers-from-here). AMP is a high-quality compounder with low exponential potential:

Forward growth: revenue CAGR FY25→FY29E ~5% ($18.9B → $23.0B); EPS CAGR ~14% as buybacks shrink the share count (weighted diluted shares fell from ~126M in 2020 to ~94M by Q1'26, a ~25% reduction). The EPS growth is real but substantially financially engineered, not organic demand.
Acceleration (the 2nd derivative): roughly flat-to-decelerating. Revenue growth was +11.5% (FY24) → +5.2% (FY25) and consensus has it settling to mid-single-digits. There is no inflection to lean on. (The FY28/FY29 EPS estimates of $54.89/$65.02 are thin — 1–2 analysts — and look aggressive; treat them as low-confidence estimates.)
Room to run: the wealth-management TAM is large, but AMP is a mature, well-penetrated ~$44B franchise competing against Morgan Stanley, Schwab, and the RIA channel. This is a share-gain grind, not a greenfield.
Reinvestment runway: modest capex; capital is returned, not reinvested for hyper-growth — appropriate for the business, but the opposite of an exponential profile.

Exponential Potential: Low (3/10). Own AMP for cheap, durable ~14% EPS compounding and capital return — not for a multibagger. A small, accelerating name with these returns on capital would score 8–9; a mature mega-cap capital-return story scores low here by design.

5. Financials (real numbers — FMP annual/quarterly)

Revenue: FY25 $18.91B, +5.2% (FY24 $17.98B, +11.5% on FY23 $16.12B). Steady, market-driven, not explosive.
Quarterly trajectory: Q1'25 $4.48B → Q2 $4.49B → Q3 $4.87B → Q4 $5.05B → Q1'26 $4.89B. Lumpy quarter-to-quarter with market and derivative-valuation noise.
Margins: gross ~51.6% TTM, operating/EBIT ~27.4% TTM, net ~20.2% TTM. On an adjusted operating basis (management's frame), the AWM segment runs a 30% pretax margin and Asset Management ~44%.
Earnings: FY25 GAAP net income $3.56B, EPS diluted $36.36. TTM GAAP diluted EPS ~$40.21. Q1'26 adjusted operating EPS a record $11.26 (+19% YoY); GAAP $9.68 (swings on derivative/market-risk-benefit valuation).
Returns on capital: ROE ~54% (ex-AOCI, TTM) — genuinely elite, among the highest in financials. ROA is low (~2%) because the balance sheet is a large insurance/annuity book — normal for the model.
Cash flow: FY25 operating cash flow ~$2.9B; near-zero capex, so FCF ≈ operating CF. Cash-flow figures are noisy given the insurance balance sheet — earnings and capital return are the cleaner tell.
Balance sheet: total debt $5.86B against $10.1B cash → net cash ~$4.2B, net-debt/EBITDA −0.95×. Total assets $191B are dominated by the separate-account/insurance book (otherLiabilities $181B), not corporate leverage. Investment-grade and well-capitalized (FMP letter rating B+).

6. Valuation — priced in or room?

AMP is genuinely cheap on earnings: ~12× trailing EPS, and on live consensus ~11× FY26E → ~10× FY27E → ~7.5× FY29E (the out-years compressing fast on the buyback-driven EPS path — though FY28/29 estimates are thin). EV/EBITDA is 7.3× and the earnings yield is ~8.5%. The one rich-looking metric is P/B 7.3×, but for a 54%-ROE business a high P/B is expected — a 54% ROE at 7.3× book still implies a ~7% earnings yield on price. The bull case for the stock is a re-rating from a depressed low-teens multiple toward the mid-teens where higher-quality asset/wealth managers trade, layered on ~5% share-count reduction a year. Street targets (context): consensus $514, high $582, low $467 — our $600 base FV is modestly above consensus because we credit both the EPS path and a partial re-rate. Not expensive; a cheap-quality-compounder buy whose upside leans on the multiple, not heroic growth.

7. Technicals (from the tech block)

Trend: mixed. $489 sits above the 50-DMA ($461.64) but only marginally above/around the 200-DMA ($472.83) — no clean golden-cross posture. MACD +3.77 (mildly positive).
Location: −10.3% off the 52-week high ($545.50), +13.7% off the 52-week low ($430.40); max drawdown from peak −14.9%. Mid-range, not a breakout.
Momentum: RSI(14) 70.0 — right at the overbought threshold, a stretched-entry caution flag after the ~12% 3-month bounce.
Relative strength (the tell): AMP −9.2% 12-mo vs SPY +20.6% and QQQ +30.3% — a material laggard over the year, though it has outpaced SPY over the last 3 months (+12.0% vs +13.7% ≈ inline). The 12-month underperformance is part of why the multiple is cheap.
Read: technicals are neutral-to-cautious — a cheap laggard bouncing into overbought territory near its 200-DMA. No urgency to chase; a pullback toward the 50-DMA (~$462) or the low-$450s would be a lower-risk entry, consistent with the "tactical" framing.

8. Moat & competitive position

Ameriprise's moat is a large, sticky advisor-and-client franchise with high switching costs: households don't casually move a full financial-planning relationship, and the shift toward fee-based wrap assets ($664B, +16% YoY) makes revenue more recurring. The AWM segment's record ~$1.2M revenue-per-advisor and 30% pretax margin show real productivity and scale. Recent client wins (Huntington National Bank's retail investment program, ~260 advisors / ~$28B assets) show the platform still takes share. The competitive weak spot is Asset Management (Columbia Threadneedle), which faces the industry-wide active-to-passive fee pressure and persistent net outflows — a structural headwind, partly offset by strong fund performance (>70% of retail funds above median across 1/3/5-yr) and expense discipline.

Peer set (market cap): Morgan Stanley $337B, Charles Schwab $169B, Apollo Global $68B, State Street $47B, AIG $42B, Prudential Financial $39B, Northern Trust $33B, Prudential plc $34B. AMP (~$44B) is a mid-cap in this group; it screens cheaper than MS/SCHW on earnings and posts a higher ROE than most, which is the crux of the value case.

9. Management, capital allocation & guidance

Capital allocation: best-in-class shareholder return. Q1'26 returned $936M, or 88% of operating earnings, to shareholders, and raised the quarterly dividend 6%. Diluted share count fell ~25% since 2020. Dividend yield ~1.3% on a modest ~25% GAAP payout — buybacks do the heavy lifting. This is a textbook capital-return compounder run by a long-tenured CEO (Jim Cracchiolo).
Insider activity: the only recent Form-filing in the window is a Form 3 (initial statement of beneficial ownership) for a newly-designated officer — no discretionary open-market selling cluster, nothing alarming.
Management's own guidance (half-weighted — their self-interested words): The Q1'26 earnings release (SEC 8-K Item 2.02, filed 2026-04-23) reads as a real earnings release. Management's own framing: adjusted operating EPS a record $11.26, +19%; AUM/A/A $1.7T, +12%; adjusted operating net revenues +11% to $4.8B; pretax adjusted operating margin 28%; AWM pretax margin 30.0% (+150 bps); ROE 54%. CEO Cracchiolo: "strong start to the year… significant revenue and earnings growth driven by the durability of our business…" and emphasized continued investment in "technology and AI capabilities." Management did not publish specific numeric full-year revenue/EPS guidance in the release — the outlook is qualitative ("durability… consistent execution"). Half-weight this as management talking its own book; the hard forward numbers here come from analyst estimates, not company guidance.

10. Catalysts & what to watch

Next earnings: 2026-07-23 (Q2'26; Street EPS $10.63, revenue ~$4.79B). Key lines: AWM net flows and margin, cash-sweep balances/spread, and Asset Management net flows (are outflows still narrowing?).
Equity-market level: the single biggest swing factor — fee AUM scales directly with markets. A drawdown hits revenue and EPS together.
Interest rates / cash-sweep spread: rate cuts compress the spread income that has boosted recent earnings — watch net investment income.
Asset Management flows: the −$5.9B Q1'26 net outflow narrowing toward flat/positive would remove a structural drag and support the re-rate.
Capital return: continued ~$900M+/quarter buybacks + dividend growth confirm the thesis.

Thesis tripwires (what would change the call): two consecutive quarters of AWM net outflows; a sharp cash-sweep spread decline; buyback pace cut materially; or the multiple pushing above ~15× (upside largely realized — trim).

11. Key risks

Market beta of earnings (structural): fee revenue is tied to equity-market levels; a bear market compresses AUM, flows, and EPS simultaneously. Beta 1.17 and a −15% drawdown show the stock reflects this.
Rate sensitivity: a meaningful share of recent earnings uplift came from net interest / cash-sweep spread; rate cuts are a direct headwind.
Asset Management outflows: persistent net outflows and active-to-passive fee pressure at Columbia Threadneedle cap growth in one of three segments.
Insurance/annuity tail: RiverSource carries market-risk-benefit and derivative-valuation swings that make GAAP EPS lumpy (Q1'26 GAAP $9.68 vs adjusted $11.26) and add long-tail liability risk.
No expert conviction / low breadth: unlike our conviction-track names, nobody we track is validating this thesis — the call rests solely on quant/fundamentals, which warrants a smaller position and humility.
Estimate quality: FY28/FY29 EPS estimates rest on 1–2 analysts and look aggressive; do not over-anchor on the out-year multiple compression.

12. Verdict, position sizing & monitoring

Buy — Tactical. AMP is a high-quality, US wealth-and-asset manager with an elite 54% ROE, a favorable mix shift toward recurring wealth-management revenue, a net-cash balance sheet, and best-in-class capital return (88% of earnings returned, dividend raised 6%) — trading at a genuinely cheap ~12× trailing / ~10× FY27E. The upside is a value re-rating plus ~5%/yr buyback-driven EPS growth, not a growth story. It earns a Tactical, not Core, label for three honest reasons: (1) no usable expert coverage in our KB — zero conviction breadth; (2) earnings are structurally levered to equity markets and rate spreads; and (3) RSI at 70 argues against chasing today.

Sizing: satellite value/quality, ~2–3% — a re-rating trade to scale into on pullbacks toward the 50-DMA (~$462) or the low-$450s, not a lump-sum core position.
Monitoring: re-underwrite on the §10 tripwires; formal re-score each earnings print. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $489.16.
Single biggest risk: earnings are levered to equity markets and rate spreads — a simultaneous market drawdown and rate-cut cycle would hit both engines at once.

Provenance & disclosures

Traceability: KB claim_count 3, breadth 0 usable, net conviction 0.0 — all three claims on file are ticker-mismatched and cited transparently as non-probative in §2 (jensen_huang-H26xnpL-ei0:959dc083da, jensen_huang_ai-H26xnpL-ei0:5e33064f11, eurodollar_university-j-JYdbUmThU:7243602aca). No expert conviction was manufactured; this is a fundamentals/quant call by design.
Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03 · KB claims through 2026-05-25. Forward figures are analyst consensus (FMP), labeled as estimates; FY28/29 estimates are thin (1–2 analysts).
Management caveat: Q1'26 8-K guidance is management's own book, half-weighted by design; no numeric full-year guidance was issued.
Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").